HÉCTOR JOSÉ
BUENO ZAMORA
Profesor asociado de Ciencias de la Salud
French Institute of Health and Medical Research
París, FranciaPublicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (9)
2022
-
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412
2021
-
The 2020 ESC-ACVC quality indicators for the management of acute myocardial infarction applied to the FAST-MI registries
European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 2, pp. 207-215
2020
-
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology
European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1298-1314
2019
-
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
European Respiratory Journal, Vol. 54, Núm. 3
2016
-
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Russian Journal of Cardiology, Vol. 131, Núm. 3, pp. 9-63
2013
-
Euro Heart Survey 2009 Snapshot: Regional variations in presentation and management of patients with AMI in 47 countries
European Heart Journal: Acute Cardiovascular Care, Vol. 2, Núm. 4, pp. 359-370
2011
-
The future of clinical trials in secondary prevention after acute coronary syndromes
European Heart Journal, Vol. 32, Núm. 13, pp. 1583-1589